Carrick Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $20M

  • Investors
  • 14

Carrick Therapeutics General Information

Description

Developer of cancer therapeutics designed to change the treatment of cancer patients and their lives. The company's therapeutics target molecular pathways that drive away aggressive and resistant forms of cancer using innovative mechanisms, enabling patients to get their predictive biomarkers detected and get their treatments started from an early stage.

Contact Information

Formerly Known As
Navillus Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Marina Park Drive
  • Suite 1410
  • Boston, MA 02210
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • One Marina Park Drive
  • Suite 1410
  • Boston, MA 02210
  • United States

Carrick Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carrick Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 16-Oct-2023 $20M Completed Clinical Trials - Phase 2
11. Later Stage VC 29-Nov-2022 Completed Clinical Trials - Phase 2
10. Later Stage VC (Series C) 03-Mar-2022 Completed Clinical Trials - Phase 2
9. Secondary Transaction - Private 15-Mar-2021 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series B2) 29-Jan-2021 Completed Clinical Trials - Phase 2
7. Early Stage VC (Series B1) 08-Nov-2019 Completed Startup
6. Secondary Transaction - Private 01-Mar-2019 Completed Startup
5. Early Stage VC 28-Dec-2018 Completed Startup
4. Early Stage VC (Series A) 18-Dec-2017 $20M $115M Completed Startup
3. Early Stage VC (Series A) 03-Oct-2016 $95M $95M Completed Startup
To view Carrick Therapeutics’s complete valuation and funding history, request access »

Carrick Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E Preferred Shares
Series D Preferred
Series C
Series C
Series B2
Series B1
Ordinary
Ordinary
Series A 24,002,052 $0.000100 $2.43 $2.43 1x $2.43 21.15%
Series A 2,057,612 $0.000100 $1.94 $1.94 1x $1.94 1.81%
To view Carrick Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Carrick Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer therapeutics designed to change the treatment of cancer patients and their lives. The company's ther
Drug Discovery
Boston, MA
23 As of 2021

Philadelphia, PA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Carrick Therapeutics Competitors (72)

One of Carrick Therapeutics’s 72 competitors is Aro Biotherapeutics, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
Mestag Therapeutics Venture Capital-Backed Cambridge, United Kingdom
Centrose Venture Capital-Backed Madison, WI
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Geneos Therapeutics Venture Capital-Backed Philadelphia, PA
You’re viewing 5 of 72 competitors. Get the full list »

Carrick Therapeutics Patents

Carrick Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025006569-A1 Combinations of estrogen receptor degraders and cdk7 inhibitors for the treatment of cancer Inactive 27-Jun-2023
US-20240383900-A1 Substituted pyrazolo [1,5-a]pyrimidine-7-amine compounds as cdk inhibitors and their therapeutic use Pending 16-Jun-2021
AU-2022294054-A1 Substituted pyrazolo[1,5-a]pyrimidine-7-amine compounds as cdk inhibitors and their therapeutic use Active 16-Jun-2021
AU-2022294054-B2 Substituted pyrazolo[1,5-a]pyrimidine-7-amine compounds as cdk inhibitors and their therapeutic use Active 16-Jun-2021
CA-3219002-A1 Substituted pyrazolo[1,5-a]pyrimidine-7-amine compounds as cdk inhibitors and their therapeutic use Pending 16-Jun-2021 C07D487/04
To view Carrick Therapeutics’s complete patent history, request access »

Carrick Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carrick Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
B Capital Group Venture Capital Minority
Pfizer Corporation Minority
Rosetta Capital (UK) Venture Capital Minority
Revelation Partners Venture Capital Minority
Nortrust Nominees Limited Partner Minority
You’re viewing 5 of 14 investors. Get the full list »

Carrick Therapeutics FAQs

  • When was Carrick Therapeutics founded?

    Carrick Therapeutics was founded in 2015.

  • Where is Carrick Therapeutics headquartered?

    Carrick Therapeutics is headquartered in Boston, MA.

  • What is the size of Carrick Therapeutics?

    Carrick Therapeutics has 23 total employees.

  • What industry is Carrick Therapeutics in?

    Carrick Therapeutics’s primary industry is Drug Discovery.

  • Is Carrick Therapeutics a private or public company?

    Carrick Therapeutics is a Private company.

  • What is the current valuation of Carrick Therapeutics?

    The current valuation of Carrick Therapeutics is .

  • What is Carrick Therapeutics’s current revenue?

    The current revenue for Carrick Therapeutics is .

  • How much funding has Carrick Therapeutics raised over time?

    Carrick Therapeutics has raised $245M.

  • Who are Carrick Therapeutics’s investors?

    B Capital Group, Pfizer, Rosetta Capital (UK), Revelation Partners, and Nortrust Nominees are 5 of 14 investors who have invested in Carrick Therapeutics.

  • Who are Carrick Therapeutics’s competitors?

    Aro Biotherapeutics, Mestag Therapeutics, Centrose, Inovio Pharmaceuticals, and Geneos Therapeutics are some of the 72 competitors of Carrick Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process